MARKET

FWP

FWP

Forward Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.48
+0.10
+1.57%
After Hours: 6.68 +0.2 +3.09% 19:47 09/22 EDT
OPEN
6.36
PREV CLOSE
6.38
HIGH
6.71
LOW
6.23
VOLUME
72.94K
TURNOVER
--
52 WEEK HIGH
20.31
52 WEEK LOW
5.76
MARKET CAP
44.66M
P/E (TTM)
-6.9083
1D
5D
1M
3M
1Y
5Y
72 Biggest Movers From Yesterday
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.
Benzinga · 09/08 08:57
Cassava Sciences, NRx Pharmaceuticals, Innate Pharma among major healthcare premarket losers' pack
Jaguar Health (NASDAQ:JAGX) -21% slumps 10% on 1-for-3 reverse stock split announcement. Forward Pharma (NASDAQ:FWP) -17% after Technical Board of Appeal of the European Patent Office has dismissed Forward’s appeal of the previous
Seekingalpha · 09/07 12:22
European ADRs Move Lower in Tuesday Trading
MT Newswires · 09/07 11:17
Why is Forward Pharma Stock Plunging During Premarket Tuesday?
The stock price of Forward Pharma A/S (NASDAQ: FWP) fell by almost 20% during the premarket. 
Benzinga · 09/07 10:08
Wall Street in Holding Pattern Pre-Bell as Traders Return After Labor Day Weekend
MT Newswires · 09/07 09:21
Forward Pharma Says European Patent Office Panel Dismisses Its Appeal Against Cancellation of Multiple Sclerosis Drug Patent
MT Newswires · 09/07 05:43
BRIEF-Forward Pharma Announces Decision Of Technical Board Of Appeal Of European Patent Office In EP2801355 Appeal Hearing
reuters.com · 09/06 17:15
Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing
COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA”) of the European Patent Office (the “EPO”) has dismissed Forward’s app...
GlobeNewswire · 09/06 14:21
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FWP. Analyze the recent business situations of Forward Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FWP stock price target is 37.00 with a high estimate of 37.00 and a low estimate of 37.00.
EPS
Institutional Holdings
Institutions: 16
Institutional Holdings: 805.66K
% Owned: 11.69%
Shares Outstanding: 6.89M
TypeInstitutionsShares
Increased
2
13.22K
New
0
0
Decreased
1
118.78K
Sold Out
3
77.81K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.30%
Pharmaceuticals & Medical Research
-0.11%
Key Executives
Chief Executive Officer
Claus Svendsen
Chief Financial Officer
Joel Sendek
Controller/Vice President
Thomas Carbone
Director/Chairman
Florian Schonharting
Director
Torsten Goesch
Director
Jan van de Winkel
Non-Executive Director
Duncan Moore
Non-Executive Director
Karen Smith
Independent Director
J. Kevin Buchi
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 23.123008
09/12/2017
About FWP
Forward Pharma A/S is a Denmark-based bio-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark.

Webull offers kinds of Forward Pharma A/S stock information, including NASDAQ:FWP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FWP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FWP stock methods without spending real money on the virtual paper trading platform.